A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Crohn Disease
- Type
- Observational
- Design
- Observational Model: Case-OnlyTime Perspective: Prospective
Participation Requirements
- Age
- Between 6 years and 17 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04312659
- Collaborators
- Not Provided
- Investigators
- Study Director: Johnson & Johnson (China) Investment Ltd. Clinical Trial Johnson & Johnson (China) Investment Ltd.
Get Well Soon